Copyright
©The Author(s) 2020.
World J Diabetes. May 15, 2020; 11(5): 165-181
Published online May 15, 2020. doi: 10.4239/wjd.v11.i5.165
Published online May 15, 2020. doi: 10.4239/wjd.v11.i5.165
Table 1 Short summary of different definitions of the term: Insulin resistance
Ref. | |
Insulin resistance is the impaired sensitivity of tissue to the action of insulin | [5] |
Insulin resistance signifies the inability of insulin at physiological concentrations to exert its normal metabolic actions. | [6] |
Insulin resistance is a diminished ability to keep the serum glucose low with insulin levels in the normal range. | [7] |
Insulin resistance is an integral concept characterizing all cases of a reduced biological effect of insulin with its normal concentration and activity. | [8] |
Insulin resistance is defined as a state of reduced responsiveness to normal circulating concentrations of insulin. | [9] |
Insulin resistance refers to state in which physiological concentrations of insulin are poorly effective. | [10] |
Insulin resistance is characterized by a reduced sensitivity of body cells to the actions of insulin. | [11] |
Insulin resistance is defined as the inability of cells to efficiently respond to stimulation by insulin. | [12] |
Table 2 Values of glucose effectiveness and insulin sensitivity1 for minimal models
Units | Control subjects | Type 2 diabetes | P value | Δ (%) | Compartment | Tracer | Ref. |
SG | |||||||
min-1 | 0.016 ± 0.001 | 0.010 ± 0.001 | < 0.01 | 37.5 | One | No | [13] |
0.020 ± 0.002 | 0.013 ± 0.001 | < 0.05 | 35.0 | One | No | [14] | |
0.023 ± 0.012 | 0.016 ± 0.009 | < 0.001 | 30.4 | One | No | [15]2 | |
h-1 | 1.20 ± 0.16 | 0.81 ± 0.11 | < 0.001 | 32.5 | One | No | [16] |
0.41 ± 0.04 | 0.33 ± 0.02 | < 0.001 | 19.5 | Two | 13C | [16] | |
0.52 ± 0.05 | 0.37 ± 0.02 | < 0.001 | 28.8 | Two | 2H | [16] | |
SI | |||||||
10-4·min-1· (mU/L)-1 | 11.8 ± 2.6 | 6.7 ± 0.8 | < 0.01 | 43.2 | One | No | [14] |
13.45 ± 11.12 | 5.31 ± 3.98 | < 0.01 | 60.5 | One | No | [15]2 | |
pmol·L-1·(h-1) | 0.0062 ± 0.0006 | 0.0019 ± 0.0006 | < 0.01 | 69.4 | One | No | [16] |
0.0082 ± 0.0012 | 0.0036 ± 0.0006 | < 0.001 | 56.1 | two | 13C | [16] | |
0.0098 ± 0.0013 | 0.0042 ± 0.0008 | < 0.001 | 57.1 | Two | 2H | [16] |
Table 3 Two-compartment minimal model analysis of the relative contribution of glucose effectiveness to the glucose restoration rate of type 2 diabetes during basal state
Units | 13C | 2H | |
SG | h-1 | 0.33 ± 0.02 | 0.37 ± 0.02 |
SI | h-1·(pmol/L)-1 | 0.0036 ± 0.0006 | 0.0042 ± 0.0008 |
SI × 1.8 × 6 | h-1 | 0.0389 ± 0.0056 | 0.0454 ± 0.0086 |
SG/(SG + SI × 10.8) | % | 89.4 | 89.1 |
Table 4 Experimental data of fully hydrated fluid phase phosphatidylcholine lipid bilayers
DLPC | DMPC | DPPC | DOPC | PDPC | |
Reference | 25 | 25 | 26,27 | 26 | 28 |
Fatty acid structure | [C12:0]2 | [C14:0]2 | [C16:0]2 | [C18:1]2 | C16:0;C22:6 |
Temperature (˚C) | 30 | 30 | 50 | 30 | 30 |
Area A per lipid molecule (Å)2 | 63.2 | 60.6 | 64.0 | 72.5 | 74.8 |
Carbon interchain distance (Å) | 4.49 | 4.39 | 4.51 | 4.80 | 4.88 |
Interaction energy U (kJ/mol) | -0.607 | -0.379 | |||
UI | 0 | 0 | 0 | 100 | 300 |
Table 5 Erythrocyte acyl composition of phospholipids and unsaturation index of control individuals, individuals with impaired glucose tolerance, and individuals with gestational diabetes mellitus1
Biochemical characteristics | IGT | GDM | ||||
Control persons(n = 42) | Persons with IGT (n = 28) | Δ (%) | Control persons(n = 61) | Persons with GDM(n = 53) | Δ (%) | |
PC | ||||||
Total SFAs (%) | 46.4 | 49.2 | + 6.0 | 42.5 | 48.3 | +24.6 |
Total MUFAs (%) | 17.8 | 19.1 | +7.3 | 13.1 | 15.8 | +20.6 |
Total PUFAs (%) | 26.8 | 22.3 | -12.5 | 37.2 | 31.1 | -16.4 |
UI | 92 | 79.5 | -13.6 | 148.1 | 114.8 | -22.5 |
PE | ||||||
Total SFAs (%) | 38.4 | 40.5 | +5.5 | 24.6 | 27.2 | +10.6 |
Total MUFAs (%) | 27.5 | 30.1 | +9.5 | 18.6 | 20.1 | +8.1 |
Total PUFAs (%) | 34.6 | 29.4 | -15.0 | 37.8 | 33.7 | -10.8 |
UI | 167.4 | 147.1 | -12.1 | 177.6 | 159.4 | -10.2 |
Table 6 Acyl composition (% of total acyl chains) of membrane phospholipids and unsaturation index in fathead minnow (Pimephales promelas) muscle1
Biochemical characteristics | 15 ˚C | 25 ˚C | 30 ˚C |
Total SFAs (%) | 17.8 | 19.9 | 38.4 |
Total MUFAs (%) | 16.1 | 16.1 | 26.6 |
Total PUFAs (%) | 65.7 | 61.5 | 34.9 |
UI | 349.9 | 325.9 | 189.9 |
Table 7 Thought experiment of multi-celled development of a single-celled, cube-shaped eukaryotic cell, which grows through cell division in a Cartesian coordinate system with the same speed in all three directions, and exchanges with its environment per unit-cell one heat unit per time unit[63]
Growth of cubic species | Number of unit cubes | Total cube | |
Required number of heat units to exchange | Number of unit-cube surface planes | ||
Original cube | 1 | 1 | 6 |
First generation | 8 (23) | 8 (23) | 24 (6 × 22) |
Second generation | 27 (33) | 27 (33) | 54 (6 × 32) |
Third generation | 64 (43) | 64 (43) | 96 (6 × 42) |
Fourth generation | 125 (53) | 125 (53) | 150 (6 × 52) |
Table 8 Erythrocyte acyl chain composition in phospholipids and unsaturation index of control individuals, people with type 2 diabetes without retinopathy, and people with type 2 diabetes with retinopathy1
Biochemical characteristics | Control individuals (n = 18) | Individuals with type 2 diabetes without retinopathy (n = 14) | Individuals with type 2 diabetes with retinopathy(n = 46) |
Total SFAs (%) | 42.0 | 44.2 | 46.9 |
Total MUFAs (%) | 18.8 | 21.7 | 21.3 |
Total PUFAs (%) | 38.0 | 31.9 | 29.5 |
UI | 155.4 | 134.3 | 123.3 |
- Citation: Weijers RN. Fundamentals about onset and progressive disease character of type 2 diabetes mellitus. World J Diabetes 2020; 11(5): 165-181
- URL: https://www.wjgnet.com/1948-9358/full/v11/i5/165.htm
- DOI: https://dx.doi.org/10.4239/wjd.v11.i5.165